八子补肾入选国内首部《中国长寿医学与抗衰产业白皮书》为 “慢老” 提供量化解决方案

Core Insights - The sixth Aging Intervention Forum highlighted the global pursuit of anti-aging solutions, bringing together leading scholars and industry leaders from top research institutions [1][2] - The release of the first "China Longevity Medicine and Anti-Aging Industry White Paper" marks a significant contribution to global anti-aging research, showcasing innovative solutions like the Ba Zi Bu Shen capsule [1][4] Group 1: Anti-Aging Focus - The core of anti-aging efforts is to "extend healthy lifespan," addressing the complexities of aging as a multi-factorial process [2] - Ba Zi Bu Shen's inclusion in the white paper is notable for its theoretical innovation and evidence-based medicine integration, providing a new approach in traditional Chinese medicine [2][4] Group 2: Research and Evidence - Ba Zi Bu Shen has conducted the largest rodent anti-aging study in China, demonstrating its ability to intervene in 10 out of 14 aging biomarkers, including mitochondrial function and inflammation regulation [3] - Results from double-blind, placebo-controlled, multi-center clinical trials show significant improvements in core symptoms of kidney essence deficiency, with a 45.79% reduction in symptom scores and a 150.04 ng/ml increase in telomerase levels [3] Group 3: Future of Anti-Aging - The publication of the white paper represents a roadmap towards national health and longevity, merging ancient wisdom with modern scientific discoveries related to aging [4] - Precision anti-aging is emerging as a health choice that individuals can actively manage, reflecting a shift towards personalized approaches in the industry [4]